Breast cancer (advanced or metastatic) - lapatinib: appeal announcement
The Institute have received one appeal from GlaxoSmithKline (GSK).
The Appeal hearing took place at NICE, MidCity Place 71 High Holborn, London WC1V 6NA - 8 June 2009 at 10:00am.
The institute awaits the decision of the appeal panel.
This page was last updated: 30 March 2010